Altered somatosensory functioning and mechanism-based classification in breast cancer patients with persistent pain.
breast cancer
cancer
mechanism-based approach
quantitative sensory testing
somatosensory functioning
Journal
Anatomical record (Hoboken, N.J. : 2007)
ISSN: 1932-8494
Titre abrégé: Anat Rec (Hoboken)
Pays: United States
ID NLM: 101292775
Informations de publication
Date de publication:
18 Nov 2022
18 Nov 2022
Historique:
revised:
27
10
2022
received:
17
06
2022
accepted:
02
11
2022
entrez:
18
11
2022
pubmed:
19
11
2022
medline:
19
11
2022
Statut:
aheadofprint
Résumé
Pain is one of the most frequent and persistent side effects of breast cancer treatment. Besides pain, breast cancer survivors (BCS) are prone to experience a myriad of other signs and symptoms related to altered somatosensory function, including for example, hypoesthesia, allodynia, and hyperalgesia, both at the local site of cancer and in remote body parts. Different breast cancer treatments can have a direct effect on somatosensory functioning, resulting in a wide range of these signs and symptoms. To our knowledge, currently no comprehensive overview exists on altered somatosensory functioning and resulting signs and symptoms in BCS with persistent pain. Investigating altered somatosensory functioning in this population could provide more insights in the underpinning pathophysiological mechanisms and consequently improve prevention and treatment in the future. Therefore, in this paper, first, normal somatosensory functioning is described. Second, quantitative sensory testing is presented as the recommend method to evaluate somatosensory functioning. Third, existing evidence on altered somatosensory functioning in BCS with persistent pain is summarized. Altered somatosensory functioning related to the most common cancer treatment modalities, including surgery and radiotherapy, hormone therapy, and chemotherapy are discussed. In addition, evidence on the presence of nociplastic pain as pain resulting from altered somatosensory functioning without evidence for nociception and/or neuropathy in BCS is summarized. At last, a discussion on this available evidence, limitations, and perspectives for clinical practice and for research are made.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022 American Association for Anatomy.
Références
Afari, N., Mostoufi, S., Noonan, C., Poeschla, B., Succop, A., Chopko, L., & Strachan, E. (2011). C-reactive protein and pain sensitivity: Findings from female twins. Annals of Behavioral Medicine, 42, 277-283.
Ahmed, M., Cook, L. J., & Douek, M. (2014). Preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Cochrane Database of Systematic Reviews, 2014, CD011229.
Allen, A. L., & McCarson, K. E. (2005). Estrogen increases nociception-evoked brain-derived neurotrophic factor gene expression in the female rat. Neuroendocrinology, 81, 193-199.
Alves Nogueira Fabro, E., Bergmann, A., do Amaral e Silva, B., Padula Ribeiro, A. C., de Souza Abrahão, K., da Costa Leite Ferreira, M. G., de Almeida Dias, R., & Santos Thuler, L. C. (2012). Post-mastectomy pain syndrome: Incidence and risks. Breast, 21, 321-325.
Andersen, K. G., Aasvang, E. K., Kroman, N., & Kehlet, H. (2014). Intercostobrachial nerve handling and pain after axillary lymph node dissection for breast cancer. Acta Anaesthesiologica Scandinavica, 58, 1240-1248.
Arendt-Nielsen, L., & Yarnitsky, D. (2009). Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. The Journal of Pain, 10, 556-572.
Augusto, C., Pietro, M., Cinzia, M., Sergio, C., Sara, C., Luca, G., & Scaioli, V. (2008). Peripheral neuropathy due to paclitaxel: Study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings. Journal of Neuro-Oncology, 86, 89-99.
Backonja, M., Attal, N., Baron, R., Bouhassira, D., Drangholt, M., Dyck, P. J., Edwards, R. R., Freeman, R., Gracely, R., Haanpaa, M. H., Hansson, P., Hatem, S. M., Krumova, E. K., Jensen, T. S., Maier, C., Mick, G., Rice, A. S., Rolke, R., Treede, R. D., … Ziegler, D. (2013). Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain, 154, 1807-1819.
Bacon, K., LaValley, M. P., Jafarzadeh, S. R., & Felson, D. (2020). Does cartilage loss cause pain in osteoarthritis and if so, how much? Annals of the Rheumatic Diseases, 79, 1105-1110.
Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA-A scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, 4, 5.
Beckwée, D., Leysen, L., Meuwis, K., & Adriaenssens, N. (2017). Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Support Care Cancer, 25, 1673-1686.
Bower, J. E. (2014). Cancer-related fatigue-Mechanisms, risk factors, and treatments. Nature Reviews. Clinical Oncology, 11, 597-609.
Boyette-Davis, J. A., Cata, J. P., Driver, L. C., Novy, D. M., Bruel, B. M., Mooring, D. L., Wendelschafer-Crabb, G., Kennedy, W. R., & Dougherty, P. M. (2013). Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemotherapy and Pharmacology, 71, 619-626.
Caro-Morán, E., Fernández-Lao, C., Díaz-Rodríguez, L., Cantarero-Villanueva, I., Madeleine, P., & Arroyo-Morales, M. (2016). Pressure pain sensitivity maps of the neck-shoulder region in breast cancer survivors. Pain Medicine, 17, 1942-1952.
Chang, P. J., Asher, A., & Smith, S. R. (2021). A targeted approach to post-mastectomy pain and persistent pain following breast cancer treatment. Cancers, 13, 5191.
Chen, Q., Zhang, W., Sadana, N., & Chen, X. (2021). Estrogen receptors in pain modulation: Cellular signaling. Biology of Sex Differences, 12, 22.
Chimenti, R. L., Frey-Law, L. A., & Sluka, K. A. (2018). A mechanism-based approach to physical therapist management of pain. Physical Therapy, 98, 302-314.
Chua, K. C., El-Haj, N., Priotti, J., & Kroetz, D. L. (2022). Mechanistic insights into the pathogenesis of microtubule-targeting agent-induced peripheral neuropathy from pharmacogenetic and functional studies. Basic & Clinical Pharmacology & Toxicology, 130(Suppl 1), 60-74.
Cliton Bezerra, M., Valentim Bittencourt, J., Reis, F. J. J., de Almeida, R. S., Meziat-Filho, N. A. M., & Nogueira, L. A. C. (2021). Central Sensitization Inventory is a useless instrument for detection of the impairment of the conditioned pain modulation in patients with chronic musculoskeletal pain. Joint, Bone, Spine, 88, 105127.
Coulombe, M.-A., Spooner, M.-F., Gaumond, I., Carrier, J. C., & Marchand, S. (2011). Estrogen receptors beta and alpha have specific pro- and anti-nociceptive actions. Neuroscience, 184, 172-182.
Dams, L., van der Gucht, E., Haenen, V., Devoogdt, N., Smeets, A., Morlion, B., Bernar, K., de Vrieze, T., Moloney, N., de Groef, A., & Meeus, M. (2022). Questionnaire-based somatosensory profiling in breast cancer survivors: Are we there yet? Associations between questionnaires and quantitative sensory testing. Disability and Rehabilitation, 1-12, 1-12. https://doi.org/10.1080/09638288.2022.2076931
Dams, L., van der Gucht, E., Meeus, M., Devoogdt, N., Smeets, A., Penen, F., de Baerdemaecker, T., Haenen, V., Bernar, K., de Vrieze, T., & de Groef, A. (2021). Quantitative sensory testing in women after surgery for breast cancer: A systematic review and narrative synthesis. The Clinical Journal of Pain, 37, 538-564.
De Groef, A., Meeus, M., De Vrieze, T., Vos, L., Van Kampen, M., Geraerts, I., & Devoogdt, N. (2018). Unraveling self-reported signs of CentralSensitization in breast cancer Survivorswith upper limb pain: Prevalence rate andContributing factors. Pain Physician, 1, E247-E256.
De Groef, A., Meeus, M., Heathcote, L. C., Wiles, L., Catley, M., Vogelzang, A., Olver, I., Runciman, W. B., Hibbert, P., Dams, L., Morlion, B., & Moseley, G. L. (2022). Treating persistent pain after breast cancer: Practice gaps and future directions. Journal of Cancer Survivorship, 11, 1-10. https://doi.org/10.1007/s11764-022-01194-z
D'Mello, R., & Dickenson, A. H. (2008). Spinal cord mechanisms of pain. British Journal of Anaesthesia, 101, 8-16.
Dougherty, P. M., Cata, J. P., Cordella, J. V., Burton, A., & Weng, H.-R. (2004). Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain, 109, 132-142.
Dubin, A. E., & Patapoutian, A. (2010). Nociceptors: The sensors of the pain pathway. The Journal of Clinical Investigation, 120, 3760-3772.
Edwards, R. R., Mensing, G., Cahalan, C., Greenbaum, S., Narang, S., Belfer, I., Schreiber, K. L., Campbell, C., Wasan, A. D., & Jamison, R. N. (2013). Alteration in pain modulation in women with persistent pain after lumpectomy: Influence of catastrophizing. Journal of Pain and Symptom Management, 46, 30-42.
Edwards, R. R., Schreiber, K. L., Dworkin, R. H., Turk, D. C., Baron, R., Freeman, R., Jensen, T. S., Latremoliere, A., Markman, J. D., Rice, A. S. C., Rowbotham, M., Staud, R., Tate, S., Woolf, C. J., Andrews, N. A., Carr, D. B., Colloca, L., Cosma-Roman, D., Cowan, P., … Wesselmann, U. (2022). Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations. The Journal of Pain, S1526-5900(22)00415-1.
Fernández-Lao, C., Cantarero-Villanueva, I., Fernández-de-las-Peñas, C., del -Moral-Ávila, R., Menjón-Beltrán, S., & Arroyo-Morales, M. (2012). Development of active myofascial trigger points in neck and shoulder musculature is similar after lumpectomy or mastectomy surgery for breast cancer. Journal of Bodywork and Movement Therapies, 16, 183-190.
Finnerup, N. B., Haroutounian, S., Kamerman, P., Baron, R., Bennett, D. L. H., Bouhassira, D., Cruccu, G., Freeman, R., Hansson, P., Nurmikko, T., Raja, S. N., Rice, A. S. C., Serra, J., Smith, B. H., Treede, R. D., & Jensen, T. S. (2016). Neuropathic pain: An updated grading system for research and clinical practice. Pain, 157, 1599-1606.
Fitzcharles, M. A., Cohen, S. P., Clauw, D. J., Littlejohn, G., Usui, C., & Häuser, W. (2021). Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet, 397, 2098-2110.
Granovsky, Y. G., & Yarnitsky, D. (2013). Personalized pain medicine: The clinical value of psychophysical assessment of pain modulation profile. Rambam Maimonides Medical Journal, 4, e0024.
Grigorian, N., & Baumrucker, S. J. (2022). Aromatase inhibitor-associated musculoskeletal pain: An overview of pathophysiology and treatment modalities. SAGE Open Medicine, 10, 20503121221078722.
Haanpää, M., Attal, N., Backonja, M., Baron, R., Bennett, M., Bouhassira, D., Cruccu, G., Hansson, P., Haythornthwaite, J. A., Iannetti, G. D., Jensen, T. S., Kauppila, T., Nurmikko, T. J., Rice, A. S. C., Rowbotham, M., Serra, J., Sommer, C., Smith, B. H., & Treede, R. D. (2011). NeuPSIG guidelines on neuropathic pain assessment. Pain, 152, 14-27.
Hall, T., Briffa, K., Schafer, A., Tampin, B., & Moloney, N. (2015). Quantitative sensory testing: Implications for clinical practice. In G. Jull, A. Moore, D. Falla, J. Lewis, C. McCarthy, & M. Sterling (Eds.), Grieve's Modern Musculoskeletal Physiotherapy (pp. 194-201). Elsevier.
Hammond, E. A., Pitz, M., Lambert, P., & Shay, B. (2019). Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain? Canadian Journal of Pain, 3, 169-177.
Hershman, D. L., Weimer, L. H., Wang, A., Kranwinkel, G., Brafman, L., Fuentes, D., Awad, D., & Crew, K. D. (2011). Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Research and Treatment, 125, 767-774.
Hoegh, M. (2022). Pain science in practice: What is pain neuroscience? Part 1. Journal of Orthopaedic & Sports Physical Therapy, 52, 163-165.
Hyder, T., Marino, C. C., Ahmad, S., Nasrazadani, A., & Brufsky, A. M. (2021). Aromatase inhibitor-associated musculoskeletal syndrome: Understanding mechanisms and management. Front Endocrinol (Lausanne), 12, 713700.
Iannetti, G. D., & Mouraux, A. (2010). From the neuromatrix to the pain matrix (and back). Experimental Brain Research, 205, 1-12.
Institute of Medicine. (1987). Pain and disability: Clinical, behavioral, and public policy perspectives. The National Academies Press. https://doi.org/10.17226/991
Izumi, M., Hayashi, Y., Saito, R., Oda, S., Petersen, K. K., Arendt-Nielsen, L., & Ikeuchi, M. (2022). Detection of altered pain facilitatory and inhibitory mechanisms in patients with knee osteoarthritis by using a simple bedside tool kit (QuantiPain). PR9, 7, e998.
Janz, N. K., Mujahid, M., Chung, L. K., Lantz, P. M., Hawley, S. T., Morrow, M., Schwartz, K., & Katz, S. J. (2007). Symptom experience and quality of life of women following breast cancer treatment. Journal of Women's Health, 16, 1348-1361.
Julius, D., & Basbaum, A. I. (2001). Molecular mechanisms of nociception. Nature, 413, 203-210.
Khan, S. Z., Nofil, S., Arif, A., Jan, M. M., Riaz, B., Farhat, N. Z., & Sherwani, K. (2021). Frequency and risk factors for post mastectomy pain syndrome [PMPS] in female breast cancer patients. Pakistan Journal of Medical and Health Sciences, 15, 2530-2533.
Kosek, E., Clauw, D., Nijs, J., Baron, R., Gilron, I., Harris, R. E., Mico, J. A., Rice, A. S. C., & Sterling, M. (2021). Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain, 162, 2629-2634.
Koulouris, A. E., Edwards, R. R., Dorado, K., Schreiber, K. L., Lazaridou, A., Rajan, S., White, J., Garcia, J., Gibbons, C., & Freeman, R. (2020). Reliability and validity of the Boston bedside quantitative sensory testing battery for neuropathic pain. Pain Medicine, 21, 2336-2347.
Laroche, F., Perrot, S., Medkour, T., Cottu, P. H., Pierga, J. Y., Lotz, J. P., Beerblock, K., Tournigand, C., Chauvenet, L., Bouhassira, D., & Coste, J. (2017). Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study. PLoS One, 12, e0187165.
Latremoliere, A., & Woolf, C. J. (2009). Central sensitization: A generator of pain hypersensitivity by central neural plasticity. The Journal of Pain, 10, 895-926.
Lewis, G. N., Luke, H., Rice, D. A., Rome, K., & McNair, P. J. (2012). Reliability of the conditioned pain modulation paradigm to assess endogenous inhibitory pain pathways. Pain Research and Management, 17, 98-102.
Leysen, L., Adriaenssens, N., Nijs, J., Pas, R., Bilterys, T., Vermeir, S., Lahousse, A., & Beckwée, D. (2019). Chronic pain in breast cancer survivors: Nociceptive, neuropathic, or central sensitization pain? Pain Practice, 19, 183-195.
Li, J., Simone, D. A., & Larson, A. A. (1999). Windup leads to characteristics of central sensitization. Pain, 79, 75-82.
Liu, Y.-L., Zhou, L. J., Hu, N. W., Xu, J. T., Wu, C. Y., Zhang, T., Li, Y. Y., & Liu, X. G. (2007). Tumor necrosis factor-α induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: The role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology, 52, 708-715.
Lorenzo-Gallego, L., Arranz-Martín, B., Romay-Barrero, H., Prieto-Gómez, V., Lluch, E., & Torres-Lacomba, M. (2022). Changes in pain sensitivity in treatment for breast cancer: A 12-month follow-up case series. International Journal of Environmental Research and Public Health, 19(7), 4055.
Manfuku, M., Nishigami, T., Mibu, A., Tanaka, K., Kitagaki, K., & Sumiyoshi, K. (2019). Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls. Breast Cancer, 26, 758-765.
Martland, M. E., Rashidi, A. S., Bennett, M. I., Fallon, M., Jones, C., Rolke, R., & Mulvey, M. R. (2020). The use of quantitative sensory testing in cancer pain assessment: A systematic review. European Journal of Pain, 24, 669-684.
Melhem, J., Amarin, M., Odeh, G., al-Bustami, N., al-Lauzy, H., & Ayoub, R. (2021). Intercostobrachial nerve (ICBN) preservation versus sacrifice in axillary dissection: Randomized controlled trial. American Journal of Clinical Oncology, 44, 206-209.
Melzack, R. (1961). The perception of pain. Scientific American, 204, 41-49.
Melzack, R. (1999). From the gate to the neuromatrix. Pain, 82, S121-S126.
Merskey, H., & Bogduk, N. (1994). Classification of chronic pain. In IASP task force on taxonomy (2nd ed.). IASP Press.
Mertens, M., Hermans, L., van Oosterwijck, J., Meert, L., Crombez, G., Struyf, F., & Meeus, M. (2020). The result of acute induced psychosocial stress on pain sensitivity and modulation in healthy people. Pain Physician, 23, E703-E712.
Mertens, M. G., Hermans, L., Crombez, G., Goudman, L., Calders, P., van Oosterwijck, J., & Meeus, M. (2020). Comparison of five conditioned pain modulation paradigms and influencing personal factors in healthy adults. European Journal of Pain, 25, 243-256. https://doi.org/10.1002/ejp.1665
Mücke, M., Cuhls, H., Radbruch, L., Baron, R., Maier, C., Tölle, T., Treede, R. D., & Rolke, R. (2021). Quantitative sensory testing (QST). English version. Schmerz, 35, 153-160.
Mustonen, L., Aho, T., Harno, H., Sipilä, R., Meretoja, T., & Kalso, E. (2019). What makes surgical nerve injury painful? A 4-year to 9-year follow-up of patients with intercostobrachial nerve resection in women treated for breast cancer. Pain, 160, 246-256.
Mustonen, L., Vollert, J., Rice, A. S. C., Kalso, E., & Harno, H. (2020). Sensory profiles in women with neuropathic pain after breast cancer surgery. Breast Cancer Research and Treatment, 182, 305-315.
Nijs, J., De Kooning, M., Beckwée, D., & Vaes, P. (2015). The neurophysiology of pain and pain modulation: Modern pain neuroscience for musculoskeletal therapists. In Grieve's modern musculoskeletal physiotherapy (pp. 8-18). Elsevier.
Nijs, J., Lahousse, A., Kapreli, E., Bilika, P., Saraçoğlu, İ., Malfliet, A., Coppieters, I., De Baets, L., Leysen, L., Roose, E., Clark, J., Voogt, L., & Huysmans, E. (2021). Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. Journal of Clinical Medicine, 10, 3203.
Nijs, J., Leysen, L., Adriaenssens, N., Aguilar Ferrándiz, M. E., Devoogdt, N., Tassenoy, A., Ickmans, K., Goubert, D., van Wilgen, C. P., Wijma, A. J., Kuppens, K., Hoelen, W., Hoelen, A., Moloney, N., & Meeus, M. (2016). Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncologica, 55, 659-663.
Pereira, S., Fontes, F., Sonin, T., Dias, T., Fragoso, M., Castro-Lopes, J. M., & Lunet, N. (2016). Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: A prospective cohort study. Support Care Cancer, 24, 1571-1581.
Rasmussen, G. H. F., Madeleine, P., Arroyo-Morales, M., Voigt, M., & Kristiansen, M. (2021). Pain sensitivity and shoulder function among breast cancer survivors compared to matched controls: A case-control study. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-021-00995-y
Reimer, M., Forstenpointner, J., Hartmann, A., Otto, J. C., Vollert, J., Gierthmühlen, J., Klein, T., Hüllemann, P., & Baron, R. (2020). Sensory bedside testing: A simple stratification approach for sensory phenotyping. Pain Report, 5, e820.
Roberts, K. E., Rickett, K., Feng, S., Vagenas, D., & Woodward, N. E. (2020). Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database of Systematic Reviews, 1, CD012988.
Rolke, R., Baron, R., Maier, C., Tölle, T. R., Treede, D. R., Beyer, A., Binder, A., Birbaumer, N., Birklein, F., Bötefür, I. C., Braune, S., Flor, H., Huge, V., Klug, R., Landwehrmeyer, G. B., Magerl, W., Maihöfner, C., Rolko, C., Schaub, C., … Wasserka, B. (2006). Quantitative sensory testing in the German research network on neuropathic pain (DFNS): Standardized protocol and reference values. Pain, 123, 231-243.
Rossettini, G., Camerone, E. M., Carlino, E., Benedetti, F., & Testa, M. (2020). Context matters: The psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy. Archives of Physiotherapy, 10, 11.
Sachau, J., Otto, J. C., Kirchhofer, V., Larsen, J. B., Kennes, L. N., Hüllemann, P., Arendt-Nielsen, L., & Baron, R. (2022). Development of a bedside tool-kit for assessing sensitization in patients with chronic osteoarthritis knee pain or chronic knee pain after total knee replacement. Pain, 163, 308-318.
Salgado, T. M., Quinn, C. S., Krumbach, E. K., Wenceslao, I., Gonzalez, M., Reed, H. L., Syverson, J. G., Etz, R. S., Vangipuram, K., Barker, M. R., Henry, N. L., Farris, K. B., & Hertz, D. L. (2020). Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: A qualitative study. Support Care Cancer, 28, 4163-4172.
Schistad, E. I., Stubhaug, A., Furberg, A.-S., Engdahl, B. L., & Nielsen, C. S. (2017). C-reactive protein and cold-pressor tolerance in the general population: The Tromsø study. Pain, 158, 1280-1288.
Schreiber, K. L., Kehlet, H., Belfer, I., & Edwards, R. R. (2014). Predicting, preventing and managing persistent pain after breast cancer surgery: The importance of psychosocial factors. Pain Management, 4, 445-459.
Singer, O., Cigler, T., Moore, A. B., Levine, A. B., Hentel, K., Belfi, L., do, H. T., & Mandl, L. A. (2012). Defining the aromatase inhibitor musculoskeletal syndrome: A prospective study. Arthritis Care & Research (Hoboken), 64, 1910-1918.
Singh, A., Nair, N. S., Gupta, S., Parmar, V., Prabhu, A., Hawaldar, R., & Badwe, R. A. (2022). Effect of menopausal status on chemotherapy-induced peripheral neuropathy: Single-institution retrospective audit. Indian Journal of Medical and Paediatric Oncology, 43, 68-72.
Sirucek, L., Ganley, R. P., Zeilhofer, H. U., & Schweinhardt, P. (2022). Diffuse noxious inhibitory controls and conditioned pain modulation: A shared neurobiology within the descending pain inhibitory system? Pain Publish ahead of print.
Sorkin, L. S., Xiao, W.-H., Wagner, R., & Myers, R. R. (1997). Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres. Neuroscience, 81, 255-262.
Starkweather, A. R., Heineman, A., Storey, S., Rubia, G., Lyon, D. E., Greenspan, J., & Dorsey, S. G. (2016). Methods to measure peripheral and central sensitization using quantitative sensory testing: A focus on individuals with low back pain. Applied Nursing Research, 29, 237-241.
Staud, R. (2013). The important role of CNS facilitation and inhibition for chronic pain. International Journal of Clinical Rheumatology, 8, 639-646.
Stein, K. D., Syrjala, K. L., & Andrykowski, M. A. (2008). Physical and psychological long-term and late effects of cancer. Cancer, 112, 2577-2592.
Straub, J. M., New, J., Hamilton, C. D., Lominska, C., Shnayder, Y., & Thomas, S. M. (2015). Radiation-induced fibrosis: Mechanisms and implications for therapy. Journal of Cancer Research and Clinical Oncology, 141, 1985-1994.
Tan, P. Y., Anand, S. P., & Chan, D. X. H. (2021). Post-mastectomy pain syndrome: A timely review of its predisposing factors and current approaches to treatment. Proceedings of Singapore Healthcare, 20101058211006419. https://doi.org/10.1177/20101058211006419
Tenti, S., Correale, P., Cheleschi, S., Fioravanti, A., & Pirtoli, L. (2020). Aromatase inhibitors-induced musculoskeletal disorders: Current knowledge on clinical and molecular aspects. International Journal of Molecular Sciences, 21, 5625.
Timmerman, H., Wilder-Smith, O. H., Steegers, M., Vissers, K., & Wolff, A. (2018). The added value of bedside examination and screening QST to improve neuropathic pain identification in patients with chronic pain. Journal of Pain Research, 11, 1307-1318.
van den Beuken-van Everdingen, M. H. J., Hochstenbach, L. M. J., Joosten, E. A. J., Tjan-Heijnen, V. C. G., & Janssen, D. J. A. (2016). Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. Journal of Pain and Symptom Management, 51, 1070-1090.e9.
van den Broeke, E. N. (2018). Central sensitization and pain hypersensitivity: Some critical considerations. F1000Research, 7, 1325.
Vardeh, D., & Naranjo, J. F. (2017). Peripheral and central sensitization. In R. J. Yong, M. Nguyen, E. Nelson, & R. D. Urman (Eds.), Pain medicine: An essential review (pp. 15-17). Springer International Publishing. https://doi.org/10.1007/978-3-319-43133-8_4
Voscopoulos, C., & Lema, M. (2010). When does acute pain become chronic? British Journal of Anaesthesia, 105, i69-i85.
Wang, L., Cohen, J. C., Devasenapathy, N., Hong, B. Y., Kheyson, S., Lu, D., Oparin, Y., Kennedy, S. A., Romerosa, B., Arora, N., Kwon, H. Y., Jackson, K., Prasad, M., Jayasekera, D., Li, A., Guarna, G., Natalwalla, S., Couban, R. J., Reid, S., … Busse, J. W. (2020). Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: A systematic review and meta-analysis of observational studies. British Journal of Anaesthesia, 125, 346-357.
Woolf, C. J., & Salter, M. W. (2000). Neuronal plasticity: Increasing the gain in pain. Science, 288, 1765-1769.
Yuksel, S. S., Chappell, A. G., Jackson, B. T., Wescott, A. B., & Ellis, M. F. (2022). Post mastectomy pain syndrome: A systematic review of prevention modalities. JPRAS Open, 31, 32-49.
Zhi, W. I., Baser, R. E., Kwon, A., Chen, C., Li, S. Q., Piulson, L., Seluzicki, C., Panageas, K. S., Harte, S. E., Mao, J. J., & Bao, T. (2021). Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Research and Treatment, 186, 761-768.
Zhu, J. J., Liu, X. F., Zhang, P. L., Yang, J. Z., Wang, J., Qin, Y., Zhang, G. L., Ren, D. Q., Cui, C. L., & Guo, X. G. (2014). Anatomical information for intercostobrachial nerve preservation in axillary lymph node dissection for breast cancer. Genetics and Molecular Research, 13, 9315-9323.